Insider Update: AEHR EVP Rogers Raises Stake to 70,390 Shares
Rhea-AI Filing Summary
Form 4 filing – Aehr Test Systems (AEHR) submitted 07/03/2025 discloses insider transactions by Vernon Rogers, Executive Vice President of Sales & Marketing.
- 13,351 common shares (Transaction Code A) were acquired on 07/02/2025 through restricted stock unit (RSU) vesting at $0 cost. Footnote 1 states 1/16 of the award vests every three months.
- An additional 1,614 common shares (Code A) vested on the same date at $0 cost; 25% of this award vested immediately, with the remainder vesting quarterly over three years (Footnote 2).
- 218 shares (Code F) were withheld at $15.13 per share to satisfy tax-withholding obligations (Footnote 3); this is not an open-market sale.
- After all transactions, Mr. Rogers directly owns 70,390 AEHR shares, which include unvested RSUs (Footnote 4). The filing notes he previously received 6,486 shares upon termination of the company’s ESOP on 04/25/2025.
No derivative securities were reported. The filing reflects routine equity compensation vesting rather than discretionary market purchases or sales.
Positive
- Executive increased direct holdings by 14,965 shares, bringing total ownership to 70,390 shares.
- No discretionary share sales; only minimal shares withheld for taxes, suggesting continued alignment with shareholders.
Negative
- Shares were acquired through zero-cost RSU vesting, offering limited insight into executive conviction at current market prices.
- Minor share withholding at $15.13 slightly increases free float, though the effect is negligible.
Insights
TL;DR: Routine RSU vesting—neutral impact; insider retains all vested shares, signaling no negative sentiment.
The Form 4 shows Mr. Rogers added 14,965 shares via scheduled RSU vesting, raising his direct stake to 70,390 shares. The only disposition—218 shares—was a tax-withholding transaction, required under equity-compensation rules. Because the acquisitions were compensation-driven at zero cost, they do not represent an opportunistic market buy. Nonetheless, the absence of discretionary selling and the decision to hold the net shares can be read as a modest confidence indicator. From a valuation or liquidity standpoint, the change is immaterial to AEHR’s float and earnings profile, so I classify the news as neutral with limited market impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 13,351 | $0.00 | -- |
| Grant/Award | Common Stock | 1,614 | $0.00 | -- |
| Tax Withholding | Common Stock | 218 | $15.13 | $3K |
Footnotes (1)
- One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. 25% of shares subject to the restricted stock unit awards shall vest immediately and the remaining 75% of shares will vest quarterly over the remaining 3 years. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. The amount reported includes shares subject to unvested restricted stock units. Mr. Vernon Rogers received 6,486 shares due to the termination of the Company's Employee Stock Ownership Plan on 04/25/2025. The closing price was $8.76 per share.
